Efgartigimod: A novel antibody depletion therapy in myasthenia gravis.
Published
Journal Article
Full Text
Duke Authors
Cited Authors
- Guidon, AC; Juel, VC
Published Date
- June 4, 2019
Published In
Volume / Issue
- 92 / 23
Start / End Page
- 1079 - 1080
PubMed ID
- 31118243
Pubmed Central ID
- 31118243
Electronic International Standard Serial Number (EISSN)
- 1526-632X
Digital Object Identifier (DOI)
- 10.1212/WNL.0000000000007605
Language
- eng
Conference Location
- United States